JYOTHYLAB Jyothy Labs Q3 FY25 results (Oct–Dec 2024) and concall
Jyothy Labs reported a mixed Q3 FY25, with strong volume growth of 8% but lower value growth of 4% due to promotional activities and higher grammages. While gross margins were protected, EBITDA margins saw a 110 bps decline. The company is focusing on diversifying away from the struggling HI segment and expanding other categories, despite a challenging demand environment and competitive pressures. The outlook for Q4 FY25 remains tough.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
| Line item | Q2 FY25 | Q3 FY25 |
|---|---|---|
| Revenue | 733 | 704 |
| EBITDA | 138 | 116 |
| Net profit | 105 | 87 |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.
